College of Food Science and Engineering, Ocean University of China, Qingdao, Shandong 266003, China.
Department of Stem Cell Research and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
J Control Release. 2022 Dec;352:371-384. doi: 10.1016/j.jconrel.2022.10.030. Epub 2022 Oct 29.
Probiotics have several health benefits to the host. However, low pH in the stomach, various digestive enzymes and bile salts in the intestine threaten their viability and function. Thus, probiotics need to be protected during gastric transit to address challenges associated with low viability and impaired function. At present, probiotic delivery systems with different trigger mechanisms have been constructed to successfully introduce numerous high-viability probiotics to the intestine. On this basis, the application of non-targeted/targeted probiotic delivery systems in different gut microenvironment and the adjuvant therapeutic effect of probiotic delivery systems on other disease were discussed in detail. It is important to also note that most of the current studies in this area focused on non-targeted probiotic delivery systems. Moreover, changes in intestinal microenvironment under disease state and discontinuous distribution of disease site limit their development. Thus, emphasis were made on the optimization of non-targeted probiotic delivery systems and the necessity of designing more precisely targeted ones.
益生菌对宿主有多种健康益处。然而,胃中的低 pH 值、肠道中的各种消化酶和胆汁盐威胁着它们的生存能力和功能。因此,益生菌需要在胃转运过程中得到保护,以应对与低存活率和功能受损相关的挑战。目前,已经构建了具有不同触发机制的益生菌输送系统,以成功地将许多高存活率的益生菌引入肠道。在此基础上,详细讨论了非靶向/靶向益生菌输送系统在不同肠道微环境中的应用,以及益生菌输送系统对其他疾病的辅助治疗效果。同样重要的是要注意,该领域的大多数当前研究都集中在非靶向益生菌输送系统上。此外,疾病状态下肠道微环境的变化和疾病部位的不连续分布限制了它们的发展。因此,重点放在了优化非靶向益生菌输送系统和设计更精确靶向系统的必要性上。